
Gaurav Bipin Shah DO
Cardiac Electrophysiology, Interventional Cardiology
Physician
Join to view full profile
2088 Ogden Ave.Aurora, IL 60504
Phone+1 630-851-6440
Fax+1 630-851-7001
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gaurav Shah, DO is a cardiologist in Aurora, Illinois. He is currently licensed to practice medicine in Illinois, Michigan, and Wisconsin. He is affiliated with Rush-Copley Medical Center, AMITA Health Mercy Medical Center, and Rush University Medical Center.
Education & Training
Advocate Health Care/Advocate Lutheran General HospitalResidency, Internal Medicine, 2006 - 2009
Des Moines University College of Osteopathic MedicineClass of 2006
Certifications & Licensure
IL State License 2008 - 2029
IL State License 2001 - 2026
MI State License 2010 - 2016
WI State License 2009 - 2012
AOA Board of Internal Medicine Cardiology
AOA Board of Internal Medicine Interventional Cardiology (CAQ)
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Press Mentions
Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association ConferenceNovember 18th, 2024
Rush Copley Named One of Best Hospitals for Treating Heart AttacksJuly 22nd, 2024
Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon DiseaseJanuary 22nd, 2019